Abstract
PeriVision VisionOne™ is a VR-based visual field testing platform for glaucoma diagnosis and monitoring.
Official Website
Clinical Performance Statistics:
Accuracy & Reliability:
Correlation with gold standard (Dynamic Strategy): r = 0.927, p < 0.001
Test-retest variability: 1.30 dB (compared to 1.71 dB for SITA standard)
Reduction in inter-test variability: 26-39%
Clinical decision agreement: Equal to Dynamic Strategy, with better agreement between SORS and DS than between different human assessors on DS alone
Device Specifications:
Hardware:
Weight: 0.6 kg (portable)
Form factor: VR headset
Test duration: ~5 minutes
Operation: Software subscription model, requires no dedicated testing room or assistant
Clinical Benefits:
Efficiency Gains:
63% reduction in technician time compared to conventional visual field testing
21-30% increase in potential patient volume (median estimate from eye doctors in market survey)
100% flexibility - can be used anywhere in the practice
95% of patients found the system easy to use
Key Advantages Over Conventional Perimetry:
Portable (vs. stationary equipment)
Cost-efficient (no dedicated room, no assistant needed)
Better data reliability (26-38% less variability)
Higher patient comfort
Intuitive dashboard for both technicians and clinicians
Technology:
Combines patented AI algorithms
VR technology for immersive testing
Cloud-based platform with separate technician and clinician dashboards
Swiss engineering
Internationally clinically validated
The system represents a significant advancement over traditional Humphrey visual field analyzers, offering comparable accuracy with much better portability, efficiency, and patient experience.
